Evidence brief · printable

Lung Cancer evidence brief

One page, every section sourced. Print it or bring it on your phone.

Print or save as PDF Fits on one A4 or Letter page.

Lung Cancer: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 (capped at 1,000 of 3,244 matching trials) · https://research.opensourcemed.info/briefs/lung-cancer.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Carboplatin 6 trials
  • Docetaxel 5 trials
  • Pembrolizumab 5 trials
  • Bevacizumab 4 trials
  • Cisplatin 4 trials
  • Nivolumab 3 trials

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • B vitamins and folate 14 trials · 8 completed · 10 with results
  • Education, coaching and self-management 58 trials · 11 completed · 5 with results
  • Multidisciplinary and other rehabilitation 15 trials · 6 completed · 1 with results
  • Care coordination, navigation and outreach 21 trials · 5 completed · 1 with results
  • Mindfulness, meditation and relaxation 10 trials · 4 completed · 1 with results
  • Physiotherapy and physical therapy 7 trials · 4 completed · 1 with results

Natural products (RepurpOS Moderate tier)

Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.

  • Cyclohexane-1,2,3,4,5,6-Hexol

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • A Study to Investigate ALE.P02 as a Monotherapy or in Combination With… NCT06747585
  • A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab… NCT06931717
  • Phase I/II Study of PLB1004 Combined With Platinum-based Doublet Chemotherapy in… NCT07063329
  • A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening… NCT07322367
  • Evaluating the Impact of Centralized Interventions on Lung Cancer Screening… NCT06324110
  • Integrating Telehealth to Advance Lung Cancer Screening NCT06638554

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Exercise and physical activity: feasibility, adherence and safety 14 trials, no results posted yet
  • Mind-body and psychological approaches: symptom severity and disease activity 10 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (315 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.